Rheumatoid arthritis: A primer for pharmacists

American Journal of Health-System Pharmacy

Volumn 63, Issue SUPPL. 4, 2006, Pages

  Marra, Carlo ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arthritis; Epidemiology; Methodology; Quality of life

Indexed keywords

AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CLINICAL FEATURE; CONFERENCE PAPER; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; PATHOPHYSIOLOGY; PHARMACIST; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SURVIVAL; SYMPTOMATOLOGY; SYNOVIUM; TREATMENT RESPONSE;

EID: 33748773676     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060362     Document Type: Conference Paper

References (23)

1. Alamanos Y, Voulgari PV, Drosos AA. Rheumatoid arthritis in southern Europe: epidemiological, clinical, radiological and genetic considerations. Curr Rheumatol Rev. 2005; 1:33-6.
2. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum. 1999; 42:415-20.
3. Doran MF, Pond GR, Crowson CS et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002; 46:625-31.
4. Klippel JH, Weyand CM, Wortmann RL, eds. Primer on the Rheumatic Diseases. 11th ed. Atlanta, GA: Arthritis Foundation; 1997.
5. Weyand CM, Schmidt D, Wagner U et al. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum. 1998; 41:817-22.
6. Gossec L, Baro-Riba J, Bozonnat MC et al. Influence of sex on disease severity in patients with rheumatoid arthritis. J Rheumatol. 2005; 32:1448-51.
7. Peschken CA, Esdaile JM. Rheumatic diseases in North America's indigenous people. Semin Arthritis Rheum. 1999; 28:368-91.
8. Ferucci ED, Templin DW, Lanier AP. Rheumatoid arthritis in American Indians and Alaska Natives: a review of the literature. Semin Arthritis Rheum. 2005; 34:662-7.
9. Majka DS, Holers VM. Can we accurately predict the development of rheumatoid arthritis in the preclinical phase? Arthritis Rheum. 2003; 48:2701-5.
10. Haraoui B, Keystone E. Rheumatoid arthritis. In: Tannenbaum H, Russell A, eds. Mechanisms in Rheumatology. Concord, Ontario, Canada: Core Health Services Inc.; 2001:42.
11. Kirwan JR. Links between radiological change, disability, and pathology in rheumatoid arthritis. J Rheumatol. 2001; 28:881-6.
12. Ollier WE, Harrison B, Symmons D. What is the natural history of rheumatoid arthritis? Best Pract Res Clin Rheumatol. 2001; 15:27-48.
13. Krishnan E, Tugwell P, Fries JF. Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI). Arthritis Res Ther. 2004; 6:R505-13.
14. Gabriel SE, Crowson CS, Kremers HM et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003; 48:54-8.
15. Verstappen SM, Bijlsma JW, Verkleij H et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004; 51:488-97.
16. Young A, Dixey J, Kulinskaya E et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis. 2002; 61:335-40.
17. Eichler HG, Mavros P, Geling O et al. Association between health-related quality of life and clinical efficacy endpoints in rheumatoid arthritis patients after four weeks treatment with anti-inflammatory agents. Int J Clin Pharmacol Ther. 2005; 43:209-16.
18. Thyberg I, Skogh T, Hass UA et al. Recent-onset rheumatoid arthritis: a 1-year observational study of correlations between health-related quality of life and clinical/laboratory data. J Rehabil Med. 2005; 37:159-65.
19. Sokka T, Hakkinen A, Krishnan E et al. Similar prediction of mortality by the Health Assessment Questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis. 2004; 63:494-7.
20. Michaud K, Messer J, Choi HK et al. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7527 patients. Arthritis Rheum. 2003; 48:2750-62.
21. Marra CA, Rashidi AA, Guh D et al. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res. 2005; 14:1333-44.
22. Marra CA, Woolcott JC, Kopec JA et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med. 2005; 60:1571-82.
23. Marra CA, Esdaile JM, Guh D et al. A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care. 2004; 42:1125-31.